Luigi Olivieri
Overview
Explore the profile of Luigi Olivieri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
893
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barlattani T, Grandinetti P, Cintio A, Montemagno A, Testa R, DAmelio C, et al.
Curr Neuropharmacol
. 2024 Sep;
22(12):2016-2033.
PMID: 39234773
Background: Since discovering the glymphatic system, there has been a looming interest in exploring its relationship with psychiatric disorders. Recently, increasing evidence suggests an involvement of the glymphatic system in...
2.
de Berardis D, Vellante F, Olivieri L, Rapini G, De Lauretis I, Orsolini L, et al.
Riv Psichiatr
. 2021 Jul;
56(3):143-148.
PMID: 34196631
Background: Schizophrenia is frequently complicated by the occurrence of depressive symptoms, anhedonia, obsessions and compulsions, suicidal ideation, and substance abuse, that causes exacerbations and remissions and, in several cases, sustained...
3.
de Berardis D, Rapini G, Olivieri L, Giardini A, De Lauretis I, Serroni N, et al.
Clin Psychopharmacol Neurosci
. 2021 Jan;
19(1):174-178.
PMID: 33508803
Cariprazine is a novel antipsychotic drug that exerts partial agonism of dopamine D/D receptors with preferential binding to the D receptor, antagonism of 5HT receptors, and partial agonism of 5HT....
4.
de Berardis D, Olivieri L, Rapini G, Serroni N, Fornaro M, Valchera A, et al.
Brain Sci
. 2020 Dec;
10(12).
PMID: 33260812
Background: This study aimed to evaluate the potential relationships between religious coping, hopelessness, and suicide ideation in adult outpatients with the first episode of major depressive disorder (MDD). Methods: Ninety-four...
5.
de Berardis D, Fornaro M, Anastasia A, Vellante F, Olivieri L, Rapini G, et al.
Braz J Psychiatry
. 2020 Mar;
42(3):317-321.
PMID: 32159712
Objective: Selective serotonin reuptake inhibitors (SSRIs) are the cornerstone of treatment of major depressive disorder (MDD). However, non-response is common, often necessitating combination strategies. The present study assessed the efficacy...
6.
de Berardis D, Vellante F, Fornaro M, Anastasia A, Olivieri L, Rapini G, et al.
Int J Psychiatry Clin Pract
. 2019 Dec;
24(1):83-87.
PMID: 31829763
The present exploratory study aimed to investigate relationships between alexithymia, suicide ideation, affective temperaments and homocysteine levels among drug-naïve adult outpatients with Post-Traumatic Stress Disorder (PTSD) in an everyday 'real...
7.
The FDA "Black Box" Warning on Antidepressant Suicide Risk in Young Adults: More Harm Than Benefits?
Fornaro M, Anastasia A, Valchera A, Carano A, Orsolini L, Vellante F, et al.
Front Psychiatry
. 2019 May;
10:294.
PMID: 31130881
The decision made in the year 2004 by the U.S. Food and Drug Administration (FDA) to require a boxed warning on antidepressants regarding the risk of suicidality in young adults...
8.
de Berardis D, Olivieri L, Rapini G, Di Natale S, Serroni N, Fornaro M, et al.
Clin Psychopharmacol Neurosci
. 2019 Mar;
17(2):318-322.
PMID: 30905133
Objective: : This study was performed to elucidate relationships between alexithymia, suicide ideation and homocysteine levels in drug-naïve outpatients with major depressive disorder (MDD). Methods: : Sixty seven outpatients with...
9.
de Berardis D, Fornaro M, Orsolini L, Olivieri L, Nappi F, Rapini G, et al.
Clin Psychopharmacol Neurosci
. 2018 Nov;
16(4):505-507.
PMID: 30466225
Clozapine may be associated with cardiovascular adverse effects including QTc prolongation and, more rarely, with myocarditis and pericarditis. Although rare, these latter cardiovascular adverse effects may be life-threatening and must...
10.
de Berardis D, Rapini G, Olivieri L, Di Nicola D, Tomasetti C, Valchera A, et al.
Ther Adv Drug Saf
. 2018 May;
9(5):237-256.
PMID: 29796248
Clozapine, a dibenzodiazepine developed in 1961, is a multireceptorial atypical antipsychotic approved for the treatment of resistant schizophrenia. Since its introduction, it has remained the drug of choice in treatment-resistant...